Literature DB >> 1382880

Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations.

L M Botana1, E Arnaez, M R Vieytes, A Alfonso, M C Louzao.   

Abstract

We studied the release of histamine elicited by some antineoplastic drugs in rat pleural and peritoneal mast cells. The drugs tested included the antibiotic mitomycin; the anthracyclines daunorubicin, doxorubicin, and epirubicin; the glycopeptide bleomycin; the chromopeptide dactinomycin; the platinum coordination complexes carboplatin and cisplatin; and the anthracenedione mitoxantrone. Mitomycin and bleomycin failed to elicit any release of histamine, whereas all of the other drugs induced histamine release from either pleural or peritoneal mast cells, the release being independent of extracellular calcium. The results indicate that antineoplastic drugs activate histamine release in a manner similar to that shown by compound 48/80, which may contribute to some of their secondary effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382880     DOI: 10.1007/BF00685603

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  17 in total

Review 1.  G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.

Authors:  M Mousli; J L Bueb; C Bronner; B Rouot; Y Landry
Journal:  Trends Pharmacol Sci       Date:  1990-09       Impact factor: 14.819

Review 2.  Protein phosphorylation and inositol phospholipid metabolism in activated mast cells.

Authors:  M Kurosawa
Journal:  Clin Exp Allergy       Date:  1990-01       Impact factor: 5.018

3.  Adriamycin-induced histamine release from rat peritoneal mast cells: role of free radicals.

Authors:  G Decorti; F B Klugmann; L Candussio; L Baldini
Journal:  Anticancer Res       Date:  1987 May-Jun       Impact factor: 2.480

4.  Toxicity of E. coli L-asparaginase in man.

Authors:  H F Oettgen; P A Stephenson; M K Schwartz; R D Leeper; L Tallai; C C Tan; B D Clarkson; R B Golbey; I H Krakoff; D A Karnofsky; M L Murphy; J H Burchenal
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

5.  Hypersensitivity reaction to cancer chemotherapy.

Authors:  R B Weiss
Journal:  Semin Oncol       Date:  1982-03       Impact factor: 4.929

Review 6.  Doxorubicin cardiotoxicity.

Authors:  D V Unverferth; R D Magorien; C V Leier; S P Balcerzak
Journal:  Cancer Treat Rev       Date:  1982-06       Impact factor: 12.111

7.  Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations.

Authors:  L M Botana; E Arnaez; M R Vieytes; A Alfonso; M C Louzao
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Valinomycin, a degranulating agent in rat mast cells which inhibits calcium-uptake.

Authors:  N Eleno; L Botana; C Segura; J Espinosa
Journal:  Agents Actions       Date:  1987-12

9.  Adrenergic activity on rat pleural and peritoneal mast cells. Loss of beta-receptors during the purification procedure.

Authors:  L M Botana; J Espinosa; N Eleno
Journal:  Gen Pharmacol       Date:  1987

10.  Single-cell analysis of Ca++ changes in human lung mast cells: graded vs. all-or-nothing elevations after IgE-mediated stimulation.

Authors:  D MacGlashan
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  2 in total

1.  Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations.

Authors:  L M Botana; E Arnaez; M R Vieytes; A Alfonso; M C Louzao
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Study of the activation mechanism of adriamycin on rat mast cells.

Authors:  M D Estévez; M R Vieytes; L M Botana
Journal:  Agents Actions       Date:  1994-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.